reviewScienceOct 17, 2019GREEN OA

Sphingosine 1-phosphate: Lipid signaling in pathology and therapy

Boston Children's Hospital · Harvard University

PubMed
Indexed incrossrefpubmed

Abstract

Sphingosine 1-phosphate (S1P), a metabolic product of cell membrane sphingolipids, is bound to extracellular chaperones, is enriched in circulatory fluids, and binds to G protein-coupled S1P receptors (S1PRs) to regulate embryonic development, postnatal organ function, and disease. S1PRs regulate essential processes such as adaptive immune cell trafficking, vascular development, and homeostasis. Moreover, S1PR signaling is a driver of multiple diseases. The past decade has witnessed an exponential growth in this field, in part because of multidisciplinary research focused on this lipid mediator and the application of S1PR-targeted drugs in clinical medicine. This has revealed fundamental principles of…

Citation impact

606
total citations
FWCI
21.36
Percentile
100%
References
147
Citations per year

Authors

2

Topics & keywords

Keywords
  • Sphingosine-1-phosphate
  • Sphingosine
  • Mediator
  • Lipid signaling
  • Neuroscience
  • Signal transduction
  • Lipid metabolism
  • Disease
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding